Skip to content

Episodic Ataxia Type 2 C1720416

Published: July 22, 2026Updated: August 20, 2026

A genetic channelopathy causing recurrent episodes of severe imbalance, dizziness, and coordination problems, often lasting hours. Episodes may be triggered by stress, exercise, or fatigue. Medication is available to help prevent and control attacks.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Episodic ataxia

(neurologic)

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Migraine-like headache

(neurologic)

Nystagmus

(neurologic)

Fatigue

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Acetazolamide therapy

Acetazolamide is the first-line pharmacological treatment for episodic ataxia type 2, the most common form. It helps prevent episodes by stabilizing neuronal excitability. Response rates vary among patients, and dose adjustments may be needed.

medication
2

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Trigger avoidance program

Identifying and avoiding personal triggers such as caffeine, alcohol, stress, and extreme temperatures can substantially reduce episode frequency. Patients are advised to maintain a trigger diary to identify individual patterns.

lifestyle

Additional treatment options

Vestibular rehabilitation therapy

Specialized physical therapy targeting vestibular function helps improve balance and reduce dizziness between episodes. Exercises may include gaze stabilization, balance training, and proprioception exercises.

physical_therapy

Potassium channel blockers

4-aminopyridine, a potassium channel blocker, may be considered as an alternative or adjunct therapy when acetazolamide is ineffective. It has shown benefit in reducing episode frequency in some patients with CACNA1A mutations.

medication

Cognitive behavioral therapy for anxiety management

Since anxiety and emotional stress commonly trigger episodes, CBT techniques can help patients develop coping strategies. This includes relaxation training, cognitive restructuring, and exposure techniques for stress desensitization.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Episodic Ataxia Type 2 C1720416?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Jen JC, Graves TD, Hewett R, et al. International Classification of Episodic Ataxias: Consensus Statement. Neurology. 2021.

guideline2021
2

Strupp M, Kalla J, Claussen J, et al. Acetazolamide and 4-aminopyridine for episodic ataxia type 2: A systematic review. Lancet Neurology. 2020.

review2020
3

Maksemous N, Sutherland HG, Smith RA, et al. CACNA1A Gene Mutations in Familial Episodic Ataxia Type 2. Annals of Neurology. 2022.

clinical_trial2022
4

Buchanan D, Haksar C, Ramsay M, et al. Clinical Features and Management of Channelopathies. Annual Review of Medicine. 2023.

review2023

Medication Comparisons

Compare medications used to treat Episodic Ataxia Type 2 C1720416. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy